Nicholasville, Kentucky (PRWEB) January 16, 2015
MediVet Biologics a company known for their focus on companion animal health with world-class lab facilities was selected by the University of Kentuckys researchers to investigate the potential of a canine cancer treatment. The team of researchers in charge of developing the K-9 ACV veterinary cancer vaccine service have dedicated decades of research toward a better understanding of how the immune system responds to cancer cells with the goal of improving cancer treatment. Leading researcher John Yanelli, Ph.D has spent over 20 years conducting successful NIH-funded clinical trials in humans with lung cancer. Dr. Yannelli has published nearly 100 articles and book chapters on the immunotherapy of human cancer and continues research to improve immunotherapeutic approaches to treat cancer. With this strong knowledge base, this outstanding team now extends their efforts toward developing an effective and affordable personalized cancer vaccine service for veterinary medicine. MediVet Biologics has successfully implemented other cutting edge human medical grade technologies in the Veterinary space such as regenerative medicine in Veterinarian clinics across the world.
Nearly 6 million dogs are diagnosed with cancer every year and greater than fifty percent of dogs over the age of ten will eventually develop cancer, making cancer the leading cause of disease-related death in dogs. Many of the dogs diagnosed have no mode of viable treatment. Cancer screening for early detection in dogs lags far behind human medicine. Consequently, canine cancers are usually diagnosed in later stages of disease, making them more difficult to treat effectively and increasing the likelihood of recurrence. Therapeutic options for treatable tumors include surgery, chemotherapy and radiation therapy. The side effects associated with chemotherapy and radiation therapy can seriously affect quality of life, making it difficult for pet owners to justify current cancer treatments for their dogs. The average cancer treatment expense is over $5,000 and could be well over $35,000.
MediVet Biologics approach is to use the entire tumor cell as the basis for the vaccine. When combined with surgical resection of primary tumors, this activates the immune system, leading to better clinical outcomes for canine cancers. This form of immunotherapy, developed at the NCI by researchers, including Dr. John Yannelli, has been used at the University of Kentucky Markey Cancer Center to treat humans with advanced non-small cell lung cancer (J. Clin Oncol., 22:2808, 2004). Read more about K9-ACV in the February issue of VPN (Veterinary Practice News).
MediVet Biologics reputation and success with in-clinic stem cell therapy adaptation and development make them an excellent fit for an autologous canine tumor vaccine service. The service in which resected tumor tissue will be processed at The University of Kentucky and MediVets lab into a therapeutic vaccine to be administered to dogs with cancer is a personalized medicine approach. MediVet Labs is set-up for state of the art maneuverability with animal biologics as well as superior high-end quality controls, SOPs and protocols.
According to the CEO, Jeremy Delk, MediVet Biologics is excited to make this announcement and offer an additional service to our existing customers as well as future customers. Most of all we look forward to offering an affordable treatment alternative to the animals and owners that need it. This initiative is part of a broader research and development program with MediVet Biologics. Along with the further development and marketing of our veterinary and stem cell business in the United States, more announcements of novel products will come throughout the year.
Veterinarians and patients are being sought in vaccine efficacy studies. To inquire about enrolling a patient please contact MediVet Biologics.
About MediVet Biologics
MediVet Biologics headquartered just outside Lexington, KY and Sydney Australia is a subsidiary of Medical Australia (MLA: ASX). MediVet Biologics has global reach including established partners in 26 countries around the world as well as strong market positioning in North America. The company provides novel treatment options based in science to the Veterinary market and provides unique customer specific service plans to ensure implementation and growth of its progressive products and services.
Medivet Biologics' mission is to set standards of excellence providing biologic solutions to the veterinary market. Our companys success, which is characterized by responsiveness and clinical excellence, has been founded on our dedication and quality innovative technologies. Veterinarians and pet owners trust MediVet Biologics to provide the quality care they expect and deserve. By providing services as though each pet were a member of our family, MediVet Biologics strives to be the preferred provider of Veterinary Regenerative Medicine products, equipment and services.
Read more here:
Medivet Biologics launches newest service, K9-ACV a personalized medicine approach to canine cancer.
- Blood cancer awareness month: learn to recognize the signs and symptoms - Commonwealth Journal's History - September 25th, 2022
- University of Kentucky Equine Research Hall of Fame announces awardees - DVM 360 - September 25th, 2022
- U.S. States With The Highest Cancer Rates - WorldAtlas - August 14th, 2022
- Robin Turner and James Piret Receive 2022 William F. Meggers Award - Spectroscopy Online - August 14th, 2022
- Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association Congress - Kentucky Today - June 13th, 2022
- College of Education professor takes Covid-19 research to Kentucky schools - WUKY - June 4th, 2022
- UV Radiation and the Skin - PubMed Central (PMC) - January 20th, 2022
- Give the Gift of Life During the Evan's Journey Blood Drive with the Red Cross January 21st - wkdq.com - January 5th, 2022
- Top 10 stories of 2021 - The Tribune | The Tribune - Ironton Tribune - January 5th, 2022
- It's time for Kentucky to talk to expectant parents about benefits of cord blood banking - Courier Journal - November 11th, 2020
- Does Talaris' Investigational Cell Therapy Have Potential to Be a 'Pipeline in a Product'? - BioSpace - November 11th, 2020
- Commentary: Kentucky's research universities UK and UofL answering the call now and for the future - User-generated content - May 24th, 2020
- The Republicans who were once so pro-life they fought over one woman on life support now want to sacrifice grandma for the economy - The Independent - April 30th, 2020
- The One Crucial Step Gov. Cuomo Hasn't Taken That Could Save Thousands Of Lives - HuffPost - April 19th, 2020
- The Pro-Life Movement Youve Never Heard Of - National Review - March 20th, 2020
- Longevity And Anti-Senescence Therapy Market Overview, Consumption, Supply, Demand & Insights - Kentucky Journal 24 - March 12th, 2020
- About Us | Stem Cell Therapy | Stem Cell Treatment ... - September 12th, 2019
- Stem Cell Therapy | Stem Cell Therapy | Stem Cell ... - September 10th, 2019
- Equine Stem Cell Therapy: The Future of Tendon Treatment ... - May 12th, 2019
- Stem Cell Louisville Kentucky 40217 - April 20th, 2019
- Adult Stem Cell Success Story | Kidney Disease | SCRF - March 31st, 2019
- Stem Cell Ashland Kentucky 41101 - March 1st, 2019
- Stem Cell Therapy Kentucky Neurology and Rehab - August 23rd, 2018
- Why Stem Cell Therapy for Pets? | MediVet Biologics - July 23rd, 2018
- Case Western Reserve University Researchers Develop Therapeutic to Enhance Tissue Repair and Regeneration - Newswise (press release) - August 8th, 2017
- Cancer survivor meets bone marrow donor days before wedding - WBNG-TV - August 8th, 2017
- McConnell: Action needed on health insurance - Richmond Register - July 9th, 2017
- Santa Monica's NASA Astronaut Randy Bresnik Live Interviews Before Space Station Mission - Santa monica Observed - July 9th, 2017
- Cloning - Wikipedia - December 7th, 2016
- The ALS Association - November 23rd, 2016
- Stem Cell Research | Central Kentucky Right to Life - November 20th, 2016
- Division of Cardiovascular Medicine School of Medicine ... - November 20th, 2016
- Louisville Man is Worlds First Cardiac Stem Cell Recipient - October 28th, 2016
- Cord Blood - Louisville, Kentucky(KY), Cord Blood Storage ... - September 8th, 2016
- Bone Marrow Transplant - Louisville, Kentucky(KY), Stem ... - September 6th, 2016
- The leukemic stem cell - PubMed Central (PMC) - August 22nd, 2016
- Can Stem Cells Really Repair Regenerate Cartilage Injuries ... - August 19th, 2016
- Rob Waddell Defeats Kidney Disease - Adult Stem Cells - July 25th, 2016
- DNC NEWS: Feverfew, Stem cells and the treatment of Cancer - October 19th, 2015
- Gill Heart Institute Researcher Explores Stem Cell Therapy ... - July 2nd, 2015
- Tag louisville Archives - Advance Stem Cell ... - June 7th, 2015
- WKU plans bone marrow registry drive - April 7th, 2015
- Research Programs at Universities and Institutions [Stem ... - March 14th, 2015
- Stem Cell Therapy for Diabetes - YouTube - March 1st, 2015
- Frontiers in Stem Cells & Regeneration - Marine Biological ... - January 10th, 2015
- Good News: Large Majorities Support Embryonic Stem Cell ... - December 27th, 2014
- How to Invest in Stem Cell Companies | eHow - December 3rd, 2014
- HIV drugs show promise in treating common eye disease - November 23rd, 2014
- 117.69 /$ (12 a.m.) - November 23rd, 2014
- Mesenchymal Stem Cells | National Stem Cell Foundation - October 27th, 2014
- Stem Cell Therapy KY - Be Medispa - October 15th, 2014
- How Do Stem Cells Differentiate? | eHow - September 27th, 2014
- Stem Cell Laboratory - Rood and Riddle - September 27th, 2014
- Worlds first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction - September 20th, 2014
- Stem Cell Scandal - August 30th, 2014
- STEM CELL SUCCESS STORIES Archives ... - August 23rd, 2014
- Genetic Disease Stem Cell Research, MS Treatments ... - August 23rd, 2014
- Kentucky Stem Cell Treatment and therapy | Stem Cell ... - August 22nd, 2014
- Kentucky Stem Cell Treatment | Stem Cell Treatments - August 22nd, 2014